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AbstrACt 
Introduction The majority of young autistic children 
display impairing emotional and behavioural dificulties 
that contribute to family stress. There is some evidence 
that behavioural parenting interventions are effective for 
reducing behavioural dificulties in autistic children, with 
less evidence assessing change in emotional dificulties. 
Previous trials have tended to use unblinded parent-report 
measures as primary outcomes and many do not employ 
an active control, limiting the conclusions that can be 
drawn.
Methods and analysis The Autism Spectrum Treatment 
and Resilience study is a pilot randomised controlled 
trial (RCT) testing the speciic effect of a 12-week 
group parenting intervention (Predictive Parenting) on 
primary and secondary outcomes, in comparison to an 
attention control condition consisting of psychoeducation 
parent groups. Following a feasibility study to test 
research procedures and the interventions, the pilot RCT 
participants include 60 parents of autistic children aged 
4–8 years who are randomised to Predictive Parenting 
versus the attention control. Measures are administered at 
baseline and post intervention to assess group differences 
in child and parent outcomes, costs and service use and 
adverse events. The primary outcome is an objective 
measure of child behaviours that challenge during 
interactions with their parent and a researcher. The trial 
aims to provide data on recruitment, retention, completion 
of measures and acceptability of the intervention and 
research protocol, in addition to providing a preliminary 
indication of potential eficacy and establishing an effect 
size that could be used to power a larger-scale eficacy 
trial. We will also provide preliminary estimates of the 
cost-effectiveness of the interventions.
Ethics and dissemination Ethical approval was granted 
from NHS Camden and Kings Cross Research Ethics 
Committee (ref: 16/LO/1769) along with NHS R&D approval 
from South London and Maudsley, Guy's and St Thomas', 
and Croydon Health Services NHS Trusts. The indings will 
be disseminated through publication in peer-reviewed 
journals and presentations at conferences.
trial registration number ISRCTN91411078
IntroduCtIon
background
Autism is characterised by difficulties in recip-
rocal social communication and the presence 
of restricted interests, repetitive behaviours 
and sensory anomalies.1 At least 1% of chil-
dren are autistic,2–4 and the condition is 
around three to four times more prevalent in 
males than in females.5 There are high rates 
strengths and limitations of this study
 Ź The trial uses an objective measure as the primary 
outcome overcoming biases associated with partici-
pants being unblinded to treatment status.
 Ź The target intervention, developed by clinicians with 
expertise in autism, is compared to an attention 
control condition to further guard against placebo 
effects.
 Ź A feasibility study with nested qualitative evalu-
ation enabled reinement of the intervention and 
research procedures prior to commencing the pilot 
randomised controlled trial (RCT).
 Ź Parents and autistic adults, referred to as patient 
and public involvement panels, were involved in 
the development of the interventions and research 
procedures.
 Ź As the study is a pilot RCT, conclusions about the 
eficacy of the intervention are not possible.
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of intellectual disability in autistic children with approxi-
mately 55% having an IQ <70.6 It has been demonstrated 
that additional psychiatric disorders frequently co-occur 
with autism at rates much higher than in the general 
population; up to 80%–90% of young autistic children 
have additional emotional or behavioural difficulties 
meeting formal diagnostic criteria, with many having two 
or more additional disorders.7–9 Anxiety disorders, atten-
tion deficit/hyperactivity disorder and opposition defiant 
disorder are most common, and these difficulties tend to 
persist over time.10 
Parents often report that it is these co-occurring diffi-
culties, which are associated with poorer parental well-
being and parental stress,11 that they would like support 
with. Universal interventions are warranted given the high 
prevalence of co-occurring emotional and behavioural 
difficulties in autistic children. However, current service 
provision in the UK usually includes the offer of psycho-
education groups that focus on teaching parents about 
autism and developing strategies to support social and 
communication functioning, rather than the commonly 
co-occurring emotional and behavioural difficulties.
Behavioural parenting interventions are recommended 
by the National Institute of Health and Care Excellence12 
for the treatment of behavioural difficulties displayed by 
young children without autism. There are a number of 
effective parenting interventions that aim to reduce such 
difficulties in young autistic children. A recent meta-anal-
ysis of eight randomised controlled trials (RCTs) of 
behavioural parenting interventions aiming to reduce 
disruptive behaviour displayed by young autistic chil-
dren13 found a moderate effect on disruptive behaviour 
when compared with controls (standardised mean 
difference=−0.59, 95% CI −0.88,–0.30). However, there 
was significant heterogeneity in the effect of parenting 
interventions on disruptive behaviour which may be due 
to sample size, mode of delivery and the focus and dura-
tion of treatment. Only one RCT included in the review 
included anxiety management techniques even though 
anxiety disorders are the most common co-occurring 
psychiatric diagnoses in autism, and ‘behaviours that 
challenge’ are often described as an observable manifes-
tation of anxiety.14 15 A recent meta-analysis of 14 RCTs of 
cognitive behavioural therapy interventions for anxiety in 
young autistic children, most of which included parental 
components, demonstrated that reductions in anxiety 
could be achieved.16
In addition, only one parenting intervention reviewed 
by Postorino et al13 included group-based sessions for 
parents, even though groups are more scalable and have 
the added benefit of providing a support network for 
parents. More than half of the included RCTs compared 
parenting interventions to a waitlist control or care as 
usual,13 limiting conclusions that can be drawn about 
the effects as participants would not be blinded to treat-
ment allocation. Being unblinded to treatment allocation 
is particularly problematic when self-report measures 
are used as primary outcomes.17 There is a need for 
objective blinded measures of behaviour to be used as 
outcome measures in trials aiming to reduce emotional 
and behavioural difficulties displayed by young autistic 
children.
Aims and objectives
The Autism Spectrum Treatment and Resilience 
(ASTAR) trial is part of a research programme that 
aims to improve mental health outcomes among autistic 
individuals (Improving Autism Mental Health: https:// 
iamhealthkcl. net/). ASTAR tests the specific effect of 
the Predictive Parenting intervention on child emotional 
and behavioural difficulties, in comparison to an atten-
tion control condition (psychoeducation parent groups). 
The aims of the ASTAR trial are to 1) examine the feasi-
bility of the intervention in terms of recruitment, reten-
tion, completion of research measures and acceptability 
to parents; 2) provide a preliminary indication of poten-
tial efficacy on the primary and secondary outcomes and 
establish an effect size (ES) that could be used to power 
a future larger-scale RCT; and 3) provide preliminary 
estimates of the cost-effectiveness of the intervention to 
inform a larger trial.
Consistent with Medical Research Council guidance on 
evaluating complex interventions,18 we first conducted 
a preliminary feasibility phase testing the proposed 
research procedures and the Predictive Parenting (target 
intervention) and psychoeducation (control) group 
interventions with families with an autistic child aged 4–8 
years. A nested qualitative evaluation was conducted to 
explore the views of parents who declined to take part, 
those who completed/dropped out of the interventions 
and the group facilitators. Findings from the feasibility 
phase were used to amend the research procedures and 
intervention manuals prior to the subsequent pilot RCT 
(see below for further information on learning from the 
feasibility phase).
The primary outcome of the pilot RCT is observed 
child behaviours that challenge, captured during a struc-
tured researcher–child and parent–child interaction 
assessment (see description of measure below for further 
details). Secondary outcomes are child compliance and 
child-centered and child-directive parenting captured 
from the same observation and parent and teacher report 
of child emotional and behavioural difficulties. We are 
also measuring the effects of the interventions on parental 
stress and well-being, parenting practices and parenting 
self-efficacy.
MEthods And AnAlysIs
learning from the feasibility phase
The aim of the feasibility phase was to test the proposed 
recruitment processes and rates, the adequacy and accept-
ability of proposed measures and obtain the views of 
parents and professionals on the research processes and 
interventions. Participants were 22 families (91% mothers 
and 9% fathers) with a child aged 4–8 years with a clinical 
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diagnosis of autism spectrum disorder (ASD). All but one 
of the children were male, and were spilt across main-
stream (n=10) and two special schools (n=12). Children 
in the special schools groups attended either a mixed 
autism-specific special school or a special school catering 
for children with severe learning difficulties co-occurring 
with autism. As intervention content is differentiated by 
child verbal ability, parents of minimally verbal children 
(n=12) attended groups separately from parents of verbal 
children (n=10).
We recruited 22 out of our target of 24 (92%) for the 
feasibility phase and we retained 20/22 (91%) families in 
the research protocol to post intervention, indicating that 
the research processes were acceptable to families. All 22 
parents gave consent for their child’s teacher to complete 
measures. Baseline teacher questionnaires were obtained 
for 20/22 (91%) children and retention of teachers at 
post intervention was high (18/22, 82%).
Parents who were interviewed reported that the 
research procedures were acceptable, although 
some felt the assessment process was lengthy. Prior to 
commencing the pilot RCT, two proposed outcome 
measures were removed to reduce burden on families 
(see our ISRCTN record for a log of outcome measures 
tested during the feasibility phase). For some parents, 
there appeared to have been a lack of clarity about the 
difference between the research and clinical teams 
and who they would have contact with at each stage of 
the study. This led to amendments in the information 
given to parents to help make this distinction clearer. 
Findings from the qualitative interviews also indicated 
that most parents reported that they found the groups 
helpful and that they enjoyed meeting other parents in 
a similar situation. Feedback on the structure, timing, 
course materials and homework led to modifications 
to the Predictive Parenting intervention. For example, 
changes were made to make the groups more accessible 
and relevant to parents of children with lower levels of 
verbal ability. The study design was also amended by 
increasing the number of families in each group (from 
six to eight) as it was a more efficient way to recruit and 
deliver the interventions. The increased group size was 
not thought to disrupt the intervention; indeed, the 
slightly larger sizes may be helpful for group dynamics. 
Further details on the feasibility study can be provided 
on contact with the research team.
Patient and public involvement
Panels of parents of autistic children and autistic adults 
have been involved in all phases of the study and assisted 
with the development of the intervention curriculums 
and adaptations for parents of minimally verbal children, 
as well as advising on the research procedures. Guidance 
and advice about language to use when speaking with 
parents about the therapy goals and research processes 
(including on the written materials such as flyers and 
information sheets) was given.
trial design
The study is a parallel-group pilot RCT. Participating fami-
lies are allocated to one of two treatment arms (Predictive 
Parenting or psychoeducational parent groups). Rando-
misation is conducted on blocks of 10–18 families on a 
ratio of 1:1, resulting in groups of 5–9 families in each 
treatment arm for any block. The randomisation algo-
rithm is run by an independent statistician within the 
Biostatistics and Health Informatics Department, IoPPN, 
King’s College London. Details of this are recorded in a 
separate randomisation specification document. Inter-
vention allocation is emailed only to the group facilitators 
to ensure that the researchers are blinded to condition.
Measures are collected at baseline, up to 2 months 
prior to the planned randomisation date and approxi-
mately 18–24 weeks after randomisation once the 12-week 
intervention has finished. Group differences in outcomes 
will be examined.
Inclusion criteria
 Ź Parent/carer of an autistic child, as confirmed by 
their clinician, aged between 4:0 years and 8:11 years.
 Ź Have sufficient spoken English to access the 
intervention.
 Ź Agree that their family doctor can be informed of 
their involvement in the trial.
Exclusion criteria
 Ź Current participation in a behavioural parenting 
intervention delivered by another service.
 Ź Child has epileptic seizures more than weekly.
 Ź Parent or child has a severe hearing or visual 
impairment.
 Ź Active significant safeguarding concerns or a current 
severe parental psychiatric disorder.
 Ź Participation in the initial feasibility phase.
Interventions
Predictive Parenting (target intervention)
Predictive Parenting builds on behavioural parenting 
interventions, an evidence-based, well-accepted and 
cost-effective approach to targeting disruptive behaviour 
in children without autism.12 It also incorporates well-es-
tablished parent-mediated cognitive-behavioural therapy 
strategies for managing child anxiety.16 It consists of 12 
weekly 2-hour groups, which extend parents’ under-
standing of autism and associated difficulties and focus 
on supporting parents to understand and manage their 
child’s emotions and behaviours (see table 1 for content 
covered in Predictive Parenting). Techniques for helping 
parents prevent and reduce disruptive behaviour and 
anxiety are taught. It also includes content on promoting 
parental self-care and stress reduction. Content is adapted 
based on child verbal ability (minimally verbal vs verbal). 
In addition to the 12 group sessions, two individual 
sessions are conducted—one between sessions 2 and 4 
and the other between sessions 10 and 12. These indi-
vidual sessions are up to 60 min long and aim to support 
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individualisation and generalisation of the strategies for 
each family. The intervention is conducted in the commu-
nity in local child and adolescent mental health services, 
libraries or schools. Further information about Predictive 
Parenting will be published in a separate manuscript.
Psychoeducational parent group (attention control condition)
‘The Seven Cs of ASD’, the attention control condition, 
also consists of 12 weekly 2-hour groups that aim to provide 
psychoeducation and social support, while not providing 
specific guidance on managing behaviours or emotions. 
Table 2 displays the content covered in each session of 
The Seven Cs of ASD. Like Predictive Parenting, content 
is adapted based on child verbal ability.
Intervention adherence
Detailed intervention manuals have been developed, 
and frequent clinical supervision is provided to reduce 
variability due to therapist effects. Checklists have been 
developed to measure intervention fidelity, which assess 
session content and group process. These are completed 
by the group facilitators after each intervention session.
sample size justiication
As this is a pilot RCT, a formal sample size calculation was 
not undertaken. We are recruiting 60 families into the 
pilot RCT. We expect that retention will be approximately 
90%, as reported by other trials of psychological interven-
tion conducted with parents of young autistic children. 
We expect a more modest ES than the 1.3 reported by 
Sofronoff et al19 as this was for a parent-reported measure 
and therefore unblinded. For the comparison of Predic-
tive Parenting and the attention control condition, power 
was calculated by a non-central χ2 method using a linear 
mixed model with baseline (baseline-outcome correla-
tion assumed 0.7) as covariate for two-tailed p=0.05, and 
intraclass correlation for within intervention group of 
0.02 and 10% drop-out. For an ES of 0.5, our study has an 
expected 95% CI of 0.08, 0.92 and power of 64%, while 
for an ES of 0.6 the expected 95% CI is 0.18, 1.02 and 
79% power.
outcomes
Table 3 displays measures that are being used in the trial 
and when they are administered. 
Primary outcome
The primary outcome measure is child behaviours 
that challenge displayed during an observation of 
researcher–child and parent–child interactions. We 
have developed the Observation Schedule for Chil-
dren with Autism–Anxiety and Behaviour (OSCA–AB) 
for the trial drawing on existing well-validated observa-
tional measures of parent– child interaction.20–23 Two 
researcher-led and six parent-led tasks are completed 
during the 18–22 min observation. Tasks aim to simu-
late everyday challenges that autistic children may face 
and find difficult. The frequency of a range of child 
behaviours that challenge (destructive behaviour, 
aggression towards themselves and others, frustrated 
vocalisations, non-compliance, avoidance and reas-
surance seeking) observed during the OSCA–AB are 
coded. As the length of the observation varies, the rate 
of child behaviours that challenge per minute is calcu-
lated. Further information about the measure will be 
published in a separate manuscript.
Secondary outcomes
Observed child compliance
The frequency of observed child compliance during the 
OSCA–AB is coded and the rate of child compliance per 
minute is calculated.
Table 2 Content covered in The Seven Cs of ASD
Group session Content
1 Introduction and understanding ASD
2 Causes of ASD
3 Concepts in ASD
4 Caring for yourself and your family: Part 1
5 Caring for yourself and your family: Part 2
6 Comorbidities in ASD: Part 1
7 Comorbidities in ASD: Part 2
8 Clinical treatments for ASD
9 Communication and advocating for your 
child
10 Classroom considerations
11 Caring for yourself and your family: Part 3
12 Recap and review
ASD, autism spectrum disorder. 
Table 1 Content covered in Predictive Parenting
Group session  Content
1 Understanding ASD
2 Becoming a behaviour predictor
3 The power of planning
4 Predictably positive household
5 Clever communication
6 Predictable praise and rewards
7 Managing challenging behaviour and 
meltdowns
8 Predictable parent action plans
9 Understanding anxiety
10 Anxiety and Unpredictability Toolkit 1
11 Anxiety and Unpredictability Toolkit 2
12 Looking forward and looking after yourself
ASD, autism spectrum disorder. 
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Observed parent behaviour
Frequencies of a range of observed parent behaviour (eg, 
positive and negative comments, commands, giving the 
child opportunity to comply, praise, physical handling 
and supportive physical guidance) during the OSCA–
AB are coded and differences between groups will be 
examined. Child-centered parenting behaviours (positive 
comments, clear commands, praise and supportive phys-
ical guidance) and child-directive parenting behaviours 
(negative comments, unclear commands, no opportu-
nity to comply and physical handling) are summed to 
produce total child-centered parenting and child-direc-
tive parenting scores. Due to variation in the length of the 
observation, rates of child-centered and child-directive 
Table 3 Administration of measures
Measure Baseline
During 
treatment
Post
intervention Completed by
Primary outcome 
  OSCA–AB child behaviours that challenge ✓ ✓ Blinded researcher
Secondary outcomes 
  OSCA–AB child compliance ✓ ✓ Blinded researcher
  OSCA–AB child-centered parenting behaviour ✓ ✓ Blinded researcher
  OSCA–AB child-directive parenting behaviour ✓ ✓ Blinded researcher
  ABC irritability and hyperactivity ✓ ✓ Parent/teacher
  ACB ✓ ✓ Parent/teacher
  HSQ-ASD ✓ ✓ Parent
  PASR ✓ ✓ Parent
  Improvement in parent-nominated target problems ✓ ✓ Parent/blinded researcher
  CGI-I ✓ ✓ Parent/blinded researcher
  APSI ✓ ✓ Parent
  CAPES-DD parent eficacy ✓ ✓ Parent
  SWEMWBS ✓ ✓ Parent
  PS ✓ ✓ Parent
  Adverse events ✓ Parent/blinded researcher
Sample characterisation 
  Demographics ✓ Parent
  SCQ-Lifetime ✓ Parent
  ADOS–2 ✓ Blinded researcher
  ABAS–3 ✓ Parent
Intervention-related measures 
  Intervention attendance ✓ Clinician
  Intervention satisfaction ✓ Parent
  Intervention idelity ✓ Clinician
Health economics measures 
  ONS personal well-being ✓ ✓ Parent
  EQ-5D quality of life ✓ ✓ Parent
  CSRI ✓ ✓ Parent/blinded researcher
  Facilitator time use ✓ Clinician
ABAS–3, Adaptive Behaviour Assessment System, third edition; ABC, aberrant behaviour checklist; ACB, assessment of concerning 
behaviour; ADOS–2, Autism Diagnostic Observation Schedule, second edition; APSI, Autism Parenting Stress Index; CAPES-DD, Child 
Adjustment and Parent Eficacy Scale-Developmental Disability; CGI-I, clinical global impression-improvement; CSRI, Client Service Receipt 
Inventory; HSQ-ASD, Home Situations Questionnaire-Autism Spectrum Disorders; ONS, Ofice of National Statistics; OSCA–AB, Observation 
Schedule for Children with Autism-Anxiety and Behaviour; PASR, Preschool Anxiety Scale Revised; PS, Parenting Scale; SCQ, Social 
Communication Questionnaire; SWEMWBS, Short Warwick-Edinburgh Mental Well-being Scale.
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parenting behaviours per minute are calculated. The 
proportion of child-centered parenting behaviour/
child-centered and child-directive parenting behaviours 
is also calculated.
Parent-reported child emotional and behavioural dificulties
Parent-rated child emotional and behavioural difficul-
ties is measured using The Aberrant Behaviour Checklist 
(ABC)24 Irritability and Hyperactivity subscales. The Assess-
ment of Concerning Behaviours (ACB) scale,25 a measure 
of child mental health and concerning behaviours devel-
oped specifically for use with autistic individuals, is also 
completed. Forty-four items are rated on a 5-point sliding 
scale anchored by opposing responses (‘not at all’ and 
‘very much’). The Home Situations Questionnaire-Au-
tism Spectrum Disorders,26 an autism-specific measure 
of child non-compliance in everyday situations is also 
administered. Parent-reported child anxiety is measured 
using the Preschool Anxiety Scale Revised,27 which taps 
into specific fears, and generalised, social and separation 
anxiety.
A narrative describing one or two of the most pressing 
problems for parents related to child emotions and 
behaviours (parent-nominated target problems) is 
elicited at baseline. Information on the presentation, 
frequency, duration, intensity and interference with daily 
function, family life and other consequences is sought.28 
The narratives are reviewed at post intervention and 
change from baseline is scored on a 9-point scale. The 
Clinical Global Impression-Improvement29 is used to rate 
overall improvement in child emotional and behavioural 
difficulties based on the parent-nominated target prob-
lems and parental perceptions of improvement.
Teacher-reported child emotional and behavioural dificulties
The ABC24 Irritability and Hyperactivity subscales are 
completed by the child’s teacher or someone involved in 
their education (eg, key worker and special educational 
needs co-ordinator). The teacher version of the ACB25 is 
also completed.
Parent-reported parenting outcomes
Parent-rated parenting stress associated with core and 
comorbid symptoms is measured using the Autism 
Parenting Stress Index30 and parenting self-efficacy is 
measured using the Child Adjustment and Parent Efficacy 
Scale-Developmental Disability Parent Efficacy subscale,31 
a 16-item scale assessing confidence in managing specific 
child behaviours. The Short Warwick-Edinburgh Mental 
Wellbeing Scale32 assesses parent reports of their own well-
being. The short version of the Parenting Scale33 is used 
to measure self-reported lax and overreactive parenting 
practices.
Sample characterisation measures
Demographic information about the family is obtained 
at baseline. Autism severity is measured at baseline 
only using the parent-reported Social Communication 
Questionnaire-Lifetime version,34 along with the Autism 
Diagnostic Observation Schedule,   second   edition (ADOS–
2).35 The ADOS–2 is the gold standard observation 
for assessing autism symptoms and is administered by 
trained researchers. The Adaptive Behaviour Assessment 
System, third edition36 is completed by parents at baseline 
and measures three broad domains of adaptive skills and 
functioning (conceptual, social and practical), resulting 
in a General Adaptive Composite score.
Intervention-related measures
Attendance at intervention sessions and retention in the 
intervention are recorded. Satisfaction with the content 
and delivery of both interventions is measured using 
questionnaires developed for study.
Health economic measures
Parental well-being and daily emotions are measured 
using the Office of National Statistics (ONS) Personal 
Wellbeing questions,37 which ask about life satisfaction, 
worth, happiness and anxiety. The 5-level EQ-5D38 is used 
to measure parent reports of their own health-related 
quality of life, and index-based values are available to 
enable quality-adjusted life years (QALYs) calculations to 
be used in the cost-effectiveness analysis.
An adapted version of the Client Service Receipt 
Inventory (CSRI)39 measures service use and cost-related 
impacts at baseline and post intervention, to inform the 
cost-effectiveness analysis. Parents are asked to retro-
spectively identify all public, private and voluntary sector 
services used by the child, as well as services used by other 
family members that are linked to the child’s autism or 
emotional and behavioural difficulties. The CSRI also 
includes information on unpaid support and employ-
ment impacts on other family members. The facilitators 
delivering the interventions track their time spent on 
intervention-related activities and travel costs to be used 
in costing the interventions.
Procedure
Children between the ages of 4 and 8 years with a diag-
nosis of ASD are recruited to the study from participating 
services following referral via local autism diagnostic 
teams, education professionals, support groups and 
consented databases. Potential participants can also self-
refer. As the intervention content is adapted based on 
child verbal ability, the groups are run separately with 
parents of minimally verbal and verbal children within 
each of our localities. Therefore, the blocks of 10–18 
families recruited for allocation to condition will be strat-
ified by verbal ability level (minimally verbal: defined by 
ADOS–2 Module 1 vs verbal children: defined as ADOS–2 
Module 2 or above) and by locality (Croydon, Bromley) 
as part of the recruitment procedure.
After initial contact and prescreening for eligibility, 
research staff obtain informed consent and conduct base-
line assessments to confirm eligibility. All families are 
assigned a unique participant ID. Questionnaire measures 
are completed online or in hard copy depending on 
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the parent’s preference. Other measures are completed 
during a visit to the research setting, over the phone or at 
the child’s school. Baseline assessments with families are 
conducted up to 2 months prior to randomisation. With 
parental consent, teachers are asked to complete ques-
tionnaires about the child’s emotional and behavioural 
difficulties at school. Post intervention assessments are 
conducted after the completion of the intervention. 
Outcome measures are sought for all families regardless 
of their participation in the treatment provided.
There are separate research and clinical teams who are 
based in different buildings and have separate supervi-
sion structures. The assessments and interventions are 
conducted in a way to avoid inadvertent divulging of 
information that could reveal allocation status. The loca-
tion and materials used during the research assessments 
are different in type and location to those used for the 
intervention sessions, avoiding any familiarity effect for 
parents. Researchers involved in conducting the assess-
ments and rating outcome measures are blinded to 
intervention content and participant condition. Group 
facilitators are blinded to primary outcome measurement.
data management, conidentiality and access
All data in the trial are anonymised. All paper records 
are filed anonymously by the participant’s unique study 
number in secure locked cabinets in the Department of 
Child and Adolescent Psychiatry, IoPPN, King’s College 
London. Consent forms are stored separately. Personal 
details (eg, name, address and telephone numbers) are 
stored in a separate encrypted database and linked by 
initial, date of birth and unique participant ID number. 
Some records from the feasibility phase are stored 
securely at York University.
Data from paper case report forms are entered on SPSS 
databases and along with other electronic data, stored 
on a King’s server folder that is accessible only to the 
research team. Double data entry will be completed on 
at least 10% of all entered data, and quality checks will 
be conducted. The principal investigator, trial statisticians 
and other members of the study team have access to final 
datasets and will undertake analysis as appropriate and 
necessary. Any arrangements for other researchers to 
have access to the data will be negotiated separately and 
the Central Office of Research Ethics Committee will be 
informed.
statistical analyses
A statistical analysis plan has been written by the trial stat-
isticians (AP and DS) and will be approved by the chief 
investigator and the Data Monitoring Committee (DMC) 
prior to any analysis being undertaken. The analyses will 
be carried out using Stata.
In accordance with Consolidated Standards of 
Reporting Trials guidelines, we will report the flow of 
participants through the trial. Descriptive statistics of 
recruitment, drop-out and completeness of assessments 
and interventions will be provided. Satisfaction and 
fidelity of the intervention will also be reported descrip-
tively. Baseline characteristics will be presented by group.
The main analysis will be via intention-to-treat, including 
all participants who were randomised. It will use statistical 
techniques for handling missing outcome data under 
a missing at random assumption, and multiple imputa-
tion for missing measures will be considered. We will test 
for a between-group change in the primary outcome at 
post intervention, using analysis of covariance (ANCOVA) 
regression predicting outcome where post intervention is 
also covaried for baseline. Dummy variables will be used 
to account for randomisation stratification and the clus-
tering effects of groups. The distribution of the primary 
outcome at baseline will be examined for evidence of 
floor effects. Where floor effects are present, a gener-
alised mixed model/structural equation modelling 
setup, in which both baseline and post intervention are 
modelled as potentially censored response variables, will 
be used with a covariance between equations that yield the 
ANCOVA estimate of treatment effect in the absence of 
censoring. Secondary outcome measures will be analysed 
in the same way. Analysis of all post intervention treat-
ment effects will be undertaken after all post intervention 
outcome measures are completed. Trial statisticians will 
remain blinded until after the primary and secondary 
outcomes are analysed.
Economic evaluation
The cost for each participant in the pilot will be derived 
by the product of the quantity of each service and support 
used and the unit cost of each of them. Unit costs will 
be based on the economic notion of opportunity costs—
which considers the value of the resource in its next best 
alternative use. Where this is not practicable, unit costs 
will be approximated by nationally representative health 
and personal social services tariffs. Where unit costs are 
not readily available from such sources, we will derive 
costs using approaches outlined in an annual compen-
dium of Unit Cost of Health and Social Care. We will use the 
most recent publication of the Unit Cost of Health and Social 
Care produced by the Personal Social Services Research 
Unit at the time of analysis. All other reported costs will 
be consistent with the price level used in that edition.40
When applying unit costs to unpaid care, we will use 
other approaches such as replacement costs. Under this 
approach, unpaid care by family and other carers will be 
costed using the average hourly rate for a local authority 
home care worker as the assumed cost for each hour of 
unpaid informal care.
Consistent with the outcome analyses, the economic 
evaluation will also conduct an intention-to-treat analysis, 
including all participants who were randomised. We will 
compute and compare comprehensively measured costs 
(for each of the two perspectives adopted: health and 
social care, public sector or societal) for the two interven-
tions. Under each perspective, the cost-effectiveness anal-
yses will bring together costs and the primary outcome 
and will compute indicative incremental cost-effectiveness 
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ratios and net benefits; the societal perspective will be 
adopted in the main analyses. In a secondary economic 
evaluation, QALY gains computed from parental EQ-5D- 
scores will be compared with costs from each perspective; 
again, the societal perspective will be adopted to facilitate 
comparisons with the main analyses. Other exploratory 
cost-effectiveness analyses will examine other outcomes 
and perspectives.
In each case, an incremental cost-effectiveness ratio will 
be computed as the mean cost difference between Predic-
tive Parenting and the attention control condition divided 
by the mean difference in change in measures of outcome 
respectively. If one treatment is indicating it is likely to be 
both more effective and costlier than the other, we would 
consider if it is worth incurring the higher costs in order 
to achieve the improved outcomes. The approach we will 
employ to reveal the nature of trade-offs such as these—
and to represent the inherent uncertainty in any evalua-
tion—will be to plot cost-effectiveness acceptability curves 
generated from bootstrap analyses. Sensitivity analyses 
will explore the impact of key assumptions such as the 
costing of unpaid care time and lost productivity, and the 
choice of outcome.
EthICs And dIssEMInAtIon
The SPIRIT reporting guidelines are followed for this 
protocol.41
For the pilot RCT, we formed a Trial Steering Committee 
(TSC) which includes an independent chair, indepen-
dent members and parent representatives (see below for 
membership). The TSC met prior to the commencement 
of the pilot RCT to agree the study protocol and will meet 
at least annually thereafter. The TSC were consulted on 
the study protocol, techniques for ascertainment and the 
focus of measurement including the primary outcome. 
They were also consulted on whether a DMC is required 
and decided that a sub-committee of the TSC (consisting 
of the chair and statistician) could act as the DMC.
Adverse events are measured at post intervention and 
include events related to child, parent and family well-
being that may not be captured by outcome measures 
(eg, increased family discord, school refusal, significant 
change in a sibling’s well-being or behaviour) as well as 
predefined standard medical events. Such events that 
arise during treatment are documented when a situa-
tion becomes known to group facilitators. The TSC and 
DMC have independent oversight of the study and are 
informed of all adverse events.
This trial will contribute to the literature on parenting 
interventions for reducing emotional and behavioural 
difficulties displayed by young autistic children. As the 
study is a pilot RCT, conclusions about the efficacy of the 
intervention are not possible. However, the study design 
enables us to consider the feasibility of conducting a large-
scale RCT to test the efficacy of Predictive Parenting. The 
findings from the pilot RCT will be disseminated through 
publication in peer-reviewed journals of general and 
special interest and presentations at national and inter-
national conferences. There will also be a general dissem-
ination programme for families including participants 
co-ordinated through our collaborators in the National 
Autistic Society.
trIAl stAtus
Protocol V.1.4, dated 04/02/2019, see our ISRCTN 
record for log of protocol amendments. Recruitment was 
completed on 16/10/2018. Post-intervention assessments 
are due for completion by 30/04/2019.
trIAl sPonsor
King’s College London and South London and Maudsley 
NHS Foundation Trust. Email:  slam- ioppn. research@ kcl. 
ac. uk.
trIAl stEErIng CoMMIttEE
Professor Alan Stein, University of Oxford (chair); 
Dr Matt Sydes, MRC Clinical Trials Unit, University 
College London (statistician, member); Dr Jacqueline 
Rodgers, University of Newcastle (member); Bridget 
Gilchrist (parent representative); Lindsay Stairs (parent 
representative).
dAtA MonItorIng CoMMIttEE
As the trial is a pilot RCT, the TSC agreed that a subgroup 
consisting of Professor Alan Stein and Dr Matt Sydes 
would act as the DMC for ASTAR.
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